Abstract
The objective of this prospective cross-sectional case-control study was to examine the prevalence of dryness symptoms and its impact on quality of life (QoL) among very long-term survivors after hematopoietic SCT (HSCT) in comparison with their respective sibling donors. Forty-four allogeneic HSCT recipients with a long-term survival (median: 17.5; range: 11–26 years) were included. Their respective, HLA-identical sibling donors served as controls. Clinical examinations included saliva flow rates (SFR) and the Schirmer's test. The presence of sicca symptoms of mouth, eyes and skin were inquired. The social functioning (SF)-36 questionnaire was applied. Recipients had lower (P<0.01) unstimulated and stimulated mean SFR than donors. Schirmer’s test results <5 mm was found in 45% of the recipients in comparison with 27% of the donors (P=0.07). Xerostomia (34 vs 4 subjects), xerophtalmia (23 vs 3) and dry skin (32 vs 12) were reported more often by the recipients than donors (P<0.001). Sicca symptoms and their objective findings correlated with QoL. The mean SF-36 scores of the donors were significantly higher than those of the recipients for physical component summary. In conclusion, sicca symptoms are common amongst long-term survivors of HSCT and affect remarkably the QoL.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Appelbaum FR . Hematopoietic-cell transplantation at 50. N Engl J Med 2007; 357: 1472–1475.
Bhatia S, Francisco L, Carter A, Sun CL, Baker KS, Gurney JG et al. Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study. Blood 2007; 110: 3784–3792.
Gratwohl A, Baldomero H, Aljurf M, Pasquini MC, Bouzas LF, Yoshimi A et al. Hematopoietic stem cell transplantation: a global perspective. J Am Dent Assoc 2010; 303: 1617–1624.
Hong CH, Napenas JJ, Hodgson BD, Stokman MA, Mathers-Stauffer V, Elting LS et al. A systematic review of dental disease in patients undergoing cancer therapy. Support Care Cancer 2010; 18: 1007–1021.
Lalla RV, Latortue MC, Hong CH, Ariyawardana A, D'Amato-Palumbo S, Fischer DJ et al. A systematic review of oral fungal infections in patients receiving cancer therapy. Support Care Cancer 2010; 18: 985–992.
Sreebny LM . Saliva in health and disease: an appraisal and update. Int Dent J 2000; 50: 140–161.
Tichelli A, Duell T, Weiss M, Socie G, Ljungman P, Cohen A et al. Late-onset keratoconjunctivitis sicca syndrome after bone marrow transplantation: incidence and risk factors. European Group or Blood and Marrow Transplantation (EBMT) Working Party on Late Effects. Bone Marrow Transplant 1996; 17: 1105–1111.
Jensen SB, Pedersen AM, Vissink A, Andersen E, Brown CG, Davies AN et al. A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: prevalence, severity and impact on quality of life. Support Care Cancer 2010; 18: 1039–1060.
Laaksonen M, Ramseier AM, Rovo A, Jensen SB, Raber-Durlacher JE, Zitzmann NU et al. Longitudinal assessment of hematopoietic stem cell transplantation and hyposalivation. J Dent Res 2011; 90: 1177–1182.
Hull KM, Kerridge I, Schifter M . Long-term oral complications of allogeneic haematopoietic SCT. Bone Marrow Transplant 2012; 47: 265–270.
Imanguli MM, Atkinson JC, Mitchell SA, Avila DN, Bishop RJ, Cowen EW et al. Salivary gland involvement in chronic graft-versus-host disease: prevalence, clinical significance, and recommendations for evaluation. Biol Blood Marrow Transplant 2010; 16: 1362–1369.
Nagler R, Marmary Y, Krausz Y, Chisin R, Markitziu A, Nagler A . Major salivary gland dysfunction in human acute and chronic graft-versus-host disease (GVHD). Bone Marrow Transplant 1996; 17: 219–224.
Westeneng AC, Hettinga Y, Lokhorst H, Verdonck L, van Dorp S, Rothova A . Ocular graft-versus-host disease after allogeneic stem cell transplantation. Cornea 2010; 29: 758–763.
Dykewicz CA . Summary of the Guidelines for Preventing Opportunistic Infections among Hematopoietic Stem Cell Transplant Recipients. Clin Infect Dis 2001; 33: 139–144.
Jancel T, Penzak SR . Antiviral therapy in patients with hematologic malignancies, transplantation, and aplastic anemia. Semin Hematol 2009; 46: 230–247.
Maertens J, Frère P, Lass-Flörl C, Heinz W, Cornely OA . Primary antifungal prophylaxis in leukaemia patients. Eur J Cancer Suppl. 2007; 5: 43–48.
Kincaid MC, Green WR . Ocular and orbital involvement in leukemia. Surv Ophthalmol. 1983; 27: 211–232.
Gedikoglu G, Altinoz MA . Differentiation-inducing liposoluble vitamin deficiency may explain frequent secondary solid tumors after hematopoietic stem cell transplantation: minireview. Neoplasma 2008; 55: 1–9.
McDiarmid S . Nutritional support of the patient receiving high-dose therapy with hematopoietic stem cell support. Can Oncol Nurs J 2002; 12: 102–115.
Duell T, van Lint MT, Ljungman P, Tichelli A, Socie G, Apperley JF et al. Health and functional status of long-term survivors of bone marrow transplantation. EBMT Working Party on Late Effects and EULEP Study Group on Late Effects. European Group for Blood and Marrow Transplantation. Ann Intern Med 1997; 126: 184–192.
Wingard JR, Curbow B, Baker F, Piantadosi S . Health, functional status, and employment of adult survivors of bone marrow transplantation. Ann Intern Med 1991; 114: 113–118.
Lopez-Jornet P, Camacho-Alonso F . Quality of life in patients with Sjögren’s syndrome and sicca complex. J Oral Rehabil 2008; 35: 875–881.
Rovo A, Daikeler T, Halter J, Heim D, Tsakiris DA, Stern M et al. Late altered organ function in very long-term survivors after allogeneic hematopoietic stem cell transplantation: a paired comparison with their HLA-identical sibling donor. Haematologica 2011; 96: 150–155.
Baerlocher GM, Rovo A, Muller A, Matthey S, Stern M, Halter J et al. Cellular senescence of white blood cells in very long-term survivors after allogeneic hematopoietic stem cell transplantation: the role of chronic graft-versus-host disease and female donor sex. Blood 2009; 114: 219–222.
Rovo A, Daikeler T, Stern M, Halter J, Studt JD, Buser A et al. Physical and not mental health is impaired in very long-term survivors after HSCT compared with their respective donors: a paired analysis. Blood 2008; 111: 1740–1741.
Ware JE Jr, Sherbourne CD . The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30: 473–483.
McHorney CA, Ware JE Jr, Raczek AE . The MOS 36-Item short-form health survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993; 31: 247–263.
Ware JE, Kosinski M, Keller SD . SF-36 Physical And Mental Health Summary Scales: A User’s Manual. New England Medical Center, The Health Institute: Boston, MA, 1994.
Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE et al. Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002; 61: 554–558.
Vissink A, Jansma J, Spijkervet FK, Burlage FR, Coppes RP . Oral sequelae of head and neck radiotherapy. Crit Rev Oral Biol Med 2003; 14: 199–212.
Eisbruch A, Ten Haken RK, Kim HM, Marsh LH, Ship JA . Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys 1999; 45: 577–587.
Shannon IL, Trodahl JN, Starcke EN . Radiosensitivity of the human parotid gland. Proc Soc Exp Biol Med 1978; 157: 50–53.
Vissink A, Mitchell JB, Baum BJ, Limesand KH, Jensen SB, Fox PC et al. Clinical management of salivary gland hypofunction and xerostomia in head-and-neck cancer patients: successes and barriers. Int J Radiat Oncol Biol Phys 2010; 78: 983–991.
Chaushu G, Itzkovitz-Chaushu S, Yefenof E, Slavin S, Or R, Garfunkel AA . A longitudinal follow-up of salivary secretion in bone marrow transplant patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995; 79: 164–169.
Dahllöf G, Bagesund M, Ringden O . Impact of conditioning regimens on salivary function, caries-associated microorganisms and dental caries in children after bone marrow transplantation. A 4-year longitudinal study. Bone Marrow Transplant 1997; 20: 479–483.
Jones LR, Toth BB, Keene HJ . Effects of total body irradiation on salivary gland function and caries-associated oral microflora in bone marrow transplant patients. Oral Surg Oral Med Oral Pathol 1992; 73: 670–676.
Buchali A, Feyer P, Groll J, Massenkeil G, Arnold R, Budach V . Immediate toxicity during fractionated total body irradiation as conditioning for bone marrow transplantation. Radiother Oncol 2000; 54: 157–162.
Majhail NS, Ness KK, Burns LJ, Sun CL, Carter A, Francisco L et al. Late effects in survivors of Hodgkin and non-Hodgkin lymphoma treated with autologous hematopoietic cell transplantation: a report from the bone marrow transplant survivor study. Biol Blood Marrow Transplant 2007; 13: 1153–1159.
Kosrirukvongs P, Chirapapaisan N, Visuthisakchai S, Issaragrisil S, Gonggetyai V . Sjogren-like syndrome after bone marrow transplantation. J Med Assoc Thai 2008; 91: 1739–1747.
Ogawa Y, Okamoto S, Wakui M, Watanabe R, Yamada M, Yoshino M et al. Dry eye after haematopoietic stem cell transplantation. Br J Ophthalmol 1999; 83: 1125–1130.
Tichelli A, Gratwohl A, Egger T, Roth J, Prunte A, Nissen C et al. Cataract formation after bone marrow transplantation. Ann Intern Med 1993; 119: 1175–1180.
Esteban JM, Somlo G . Skin biopsy in allogeneic and autologous bone marrow transplant patients: a histologic and immunohistochemical study and review of the literature. Mod Pathol 1995; 8: 59–64.
Kim SJ, Choi JM, Kim JE, Cho BK, Kim DW, Park HJ . Clinicopathologic characteristics of cutaneous chronic graft-versus-host diseases: a retrospective study in Korean patients. Int J Dermatol 2010; 49: 1386–1392.
Champey J, Corruble E, Gottenberg JE, Buhl C, Meyer T, Caudmont C et al. Quality of life and psychological status in patients with primary Sjogren’s syndrome and sicca symptoms without autoimmune features. Arthritis Rheum 2006; 55: 451–457.
Acknowledgements
This work was supported by the Swiss National Science Foundation (Nr 3200B0-118176), the Horten Foundation and the Werner Geissberger Foundation.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Daikeler, T., Mauramo, M., Rovó, A. et al. Sicca symptoms and their impact on quality of life among very long-term survivors after hematopoietic SCT. Bone Marrow Transplant 48, 988–993 (2013). https://doi.org/10.1038/bmt.2012.260
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2012.260
Keywords
This article is cited by
-
The effect of hematopoietic stem cell transplantation on patient-reported subjective oral dryness: a systematic review focusing on prevalence, severity and distress
Supportive Care in Cancer (2023)
-
Periodontal diseases, caries, and dental abscesses prevalence in hematopoietic stem cell transplant recipients
Bone Marrow Transplantation (2021)
-
Oral disorders in patients with newly diagnosed haematological diseases
Clinical Oral Investigations (2020)
-
Determinants of stimulated salivary flow among haematopoietic stem cell transplantation recipients
Clinical Oral Investigations (2017)
-
Clinical approach in the management of oral chronic graft-versus-host disease (cGVHD) in a series of specialized medical centers
Supportive Care in Cancer (2015)